Article

Multi-omics data integration and network-based analysis drives a multiplex drug repurposing approach to a shortlist of candidate drugs against COVID-19

2020-09-18

Abstract excerpt

<title>Abstract</title> <p>The SARS-CoV-2 pandemic is undeniably the most severe global health emergency since the 1918 Influenza outbreak. Depending on its evolutionary trajectory, the virus is expected to establish itself as an endemic infectious respiratory disease exhibiting seasonal flare-ups. Therefore, despite the unprecedented rally to reach a vaccine that can offer widespread immunization, it is equally...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 52d3d33e-289d-5f55-871d-0cf44c6a0f97
DOI: 10.21203/rs.3.rs-78933/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Multi-omics data integration and network-based analysis drives a multiplex drug repurposing approach to a shortlist of candidate drugs against COVID-19DOI 10.21203/rs.3.rs-78933/v1Read

A Connectivity Map-Based Drug Repurposing Study and Integrative Analysis of Transcriptomic Profiling of SARS-CoV-2 InfectionSemantic proximity Read

Recognition of plausible therapeutic agents to combat COVID-19: An omics data based combined approachSemantic proximity Read

Identification of candidate repurposable drugs to combat COVID-19 using a signature-based approachSemantic proximity Read

Global multi-omics and systems pharmacological strategy unravel the multi-targeted therapeutic potential of natural bioactive molecules against COVID-19: An in silico approachSemantic proximity Read

Network bioinformatics analysis provides insight into drug repurposing for COVID-19Semantic proximity Read

A genetically based computational drug repurposing framework for rapid identification of candidate compounds: application to COVID-19Semantic proximity Read

Identification of new drug treatments to combat COVID19: A signature-based approach using iLINCSSemantic proximity Read

Translating GWAS Findings to Inform Drug Repositioning Strategies for COVID-19 TreatmentSemantic proximity Read

COVID-19: A Drug Repurposing and Biomarker Identification by Using Comprehensive Gene-Disease Associations through Protein-Protein Interaction Network AnalysisSemantic proximity Read

Drug Repurposing of potential drug targets for treatment of COVID-19Semantic proximity Read

Transcriptome and SARS-CoV-2 biological network directed analysis for better therapeutic developmentSemantic proximity Read

Bayesian model infers drug repurposing candidates for treatment of COVID-19Semantic proximity Read